← Back to BVS

Bioventus Inc. - Class A Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 06/05/2026Sep 2025Filed 04/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 06/05/2026Sep 2024Filed 04/11/2025Jun 2024Filed 06/08/2025Mar 2024Filed 06/05/2025
$153$132$139$148$124$139$151$129
$33$3.1$3.2$7.5−$2.6−$5.2−$26−$4.9
$0.47$0.04$0.05$0.11−$0.04−$0.08−$0.40−$0.08
7170696966656463

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.